Topics

[Comment] Confronting the persisting threat of the Middle East respiratory syndrome to global health security

21:22 EDT 3 Jul 2019 | The Lancet

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a priority zoonotic pathogen of humans highlighted in the WHO research and development blueprint list requiring urgent action1 because it has epidemic potential, a high fatality rate with no specific treatment or vaccine, and a wide geographical distribution of the host reservoir of dromedary camels in the Middle East, Africa, and Asia.2

Original Article: [Comment] Confronting the persisting threat of the Middle East respiratory syndrome to global health security

NEXT ARTICLE

More From BioPortfolio on "[Comment] Confronting the persisting threat of the Middle East respiratory syndrome to global health security"

Quick Search

Relevant Topic

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...